-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Verve Therapeutics (VERV)
-
-
-
-
-
-
-
Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Verve Therapeutics (VERV) Reports Q1, Provides Pipeline Progress Update
-
-
-
-
-
-
-
Verve Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results
-
-
-
-
-
-
-
Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2021 Financial Results
-
-
-
-
-
1,197,396 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

